IRIS
CRESTA, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.229
Totale 1.229
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.229
Totale 1.229
Salva come PNG Salva come JPEG
Città #
Genova 704
Genoa 186
Vado Ligure 170
Rapallo 167
Bordighera 2
Totale 1.229
Salva come PNG Salva come JPEG
Nome #
Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients 172
Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients 162
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients. 153
Pathological role of the calpain/calpastatin system in cystic fibrosis 138
The calpain-calpastatin system in cystic fibrosis: physiopathological implications 121
The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin 113
Verso un approccio personalizzato per il trattamento del difetto di base in Fibrosi Cistica 102
Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells 70
The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs 53
A case of interference in testosterone, DHEA-S and progesterone measurements by second generation immunoassays 48
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method 35
Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background 33
Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators 22
Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica 15
Quantification of Ivacaftor, Tezacaftor and Elexacaftor in plasma of cystic fibrosis patients treated with Kaftrio by a validated liquid chromatography-tandem mass spectrometric (LC-MS/MS) method” 9
QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD 9
Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study 6
One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study 6
Totale 1.267
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.463
article - articoli 3.302
book - libri 0
conference - conferenze 824
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.589
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020166 0 0 0 0 0 28 32 16 20 31 32 7
2020/202199 5 5 17 10 1 9 12 7 8 7 9 9
2021/2022143 2 3 16 8 4 8 8 30 4 15 25 20
2022/2023207 13 22 0 29 18 31 4 16 37 3 33 1
2023/2024141 5 10 6 19 17 26 6 8 2 4 16 22
2024/2025191 16 29 22 32 34 58 0 0 0 0 0 0
Totale 1.267